Dolby Laboratories Common Stock (DLB)
EBITDA Margin
20.77%
Quarterly · Period ending:
DLB EBITDA Margin
Latest reported20.77%period ending
Latest reported20.77%period ending
DLB Quarterly EBITDA Margin (57.28% → 20.77%)
Quarterly ebitda margin
High-resolution chart · PNG
DLB ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 20.7685% | |
| 37.0409% | |
| 29.5735% | |
| 19.6662% | |
| 22.656% | |
| 39.1483% | |
| 31.162% | |
| 27.5969% | |
| 24.7114% | |
| 39.099% | |
| 32.2565% | |
| 11.4571% | |
| 16.1079% | |
| 37.7429% | |
| 36.5292% | |
| 19.2459% | |
| 26.4748% | |
| 20.8795% | |
| 33.8031% | |
| 29.8619% | |
| 30.2069% | |
| 35.9691% | |
| 49.5863% | |
| 22.6671% | |
| 25.7897% | |
| 37.165% | |
| 25.5906% | |
| 26.2895% | |
| 21.1197% | |
| 38.6604% | |
| 31.1807% | |
| 15.6868% | |
| 6.9401% | |
| 36.2282% | |
| 38.871% | |
| 19.1103% | |
| 38.2069% | |
| 33.0668% | |
| 33.6099% | |
| 22.3763% | |
| 37.0017% | |
| 38.7162% | |
| 25.4665% | |
| 34.9726% | |
| 27.8962% | |
| 35.6573% | |
| 30.2325% | |
| 31.795% | |
| 29.216% | |
| 41.5683% | |
| 33.05% | |
| 33.4698% | |
| 27.5501% | |
| 39.5294% | |
| 33.8801% | |
| 37.4679% | |
| 36.9675% | |
| 50.5539% | |
| 47.154% | |
| 53.4586% | |
| 47.0993% | |
| 51.9754% | |
| 48.8015% | |
| 49.9857% | |
| 46.4839% | |
| 59.0491% | |
| 49.7889% | |
| 44.0715% | |
| 45.768% | |
| 57.8394% | |
| 67.8882% | |
| 43.3096% | |
| 48.1217% | |
| 4.052% | |
| 48.5053% | |
| 43.024% | |
| 36.4785% | |
| 40.5852% | |
| 35.4867% | |
| 47.6303% | |
| 28.1986% | |
| 38.0811% | |
| 26.1313% | |
| 33.9833% | |
| 32.9598% | |
| 23.6178% | |
| 21.5172% | |
| -97.9587% | |
| 61.3623% | |
| 63.2576% | |
| 59.956% | |
| -74.556% | |
| 57.557% | |
| 58.8386% | |
| 57.2781% |